Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Genomic Study of Cardiovascular Continuum Comorbidity
O A Makeeva1, A A Sleptsov2, E V Kulish2
1Research Institute of Medical Genetics, Nab. Ushayki, 10, Tomsk, 634050, Russia ; Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Blvd., 6, Kemerovo, 650000, Russia.
Genetic analysis reveals distinct profiles for single versus multiple cardiovascular diseases. Understanding these genetic differences is crucial for personalized medicine and comorbidity research.
Area of Science:
- Genetics and Genomics
- Cardiovascular Disease Research
- Personalized Medicine
Background:
- Comorbidity, the presence of multiple diseases in one individual, is common but its genetic basis is not fully understood.
- Genomic data analysis offers new approaches to investigate the genetic profiles of patients with multiple diseases (polypathia) compared to those with single diseases.
Purpose of the Study:
- To investigate the genetic background of non-random combinations of cardiovascular disorders.
- To compare the genetic profiles of patients with single ischemic heart disease (IHD), combined IHD and arterial hypertension (AH), and multiple cardiovascular continuum (CVC) diseases.
Main Methods:
- An association study was conducted with three patient groups: IHD only, IHD and AH, and multiple CVC diseases (including IHD, AH, type 2 diabetes mellitus, and hypercholesterolemia).
- A control group of relatively healthy individuals was included.
- Genotyping of 1,400 polymorphic genetic variants was performed using the 'My Gene' genomic service.
Main Results:
- 14 polymorphic variants were associated with 'IHD only', 13 with 'IHD and AH', and 14 with 'multiple CVC diseases'.
- Specific genetic markers were identified for each phenotype, with some shared markers between 'IHD only' and 'IHD and AH' (e.g., SCARB1 gene variant rs4765623).
- Lipid-metabolizing genes were implicated in all CVC variants, while immunity-response genes were specific to the 'IHD only' phenotype.
Conclusions:
- The genetic profiles of combined cardiovascular diseases differ significantly from isolated forms.
- Comorbidity presents unique challenges in genetic association studies for disease predisposition.
- Identifying distinct genetic markers for different comorbidity patterns is essential for advancing personalized medicine approaches.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

